STUDI PENGGUNAAN KEMOTERAPI PADA PASIEN LIMFOMA NON HODGKIN TIPE DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) (Penelitian dilakukan di RSUD Dr. Soetomo Surabaya)

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. DAFTAR PUSTAKA Adams, Val R., and Yee, Gary C. 2008. Chapter 135 : Lhymphomas In: Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., and Posey, L.M. (Eds.). Pharmacotherapy: A Pathophysiologic Approach 7th Edition. United State of America: The McGraw-Hill Education, p. 2219-2243. Amaka, Ediani and Shirali, Anushree. 2016. Tumor Lysis Syndrome. In: Parazella, M.A., Rosner, M.H., Finkel, W.K. Onco-Nephrology Curriculum. American Society of Nephrology, p. 1-6. American Cancer Society. 2017. Cancer Facts & Figures 2017. Atlanta: American Cancer Society, p. 4; 19-20. American Cancer Society. 2018. Chemotherapy for Non-Hodgkin Lymphoma. American Cancer Society. https://www.cancer.org/cancer/non-hodgkin lymphoma.html. (Diakses tanggal 28 Oktober 2018). American Society of Clinical Oncology (ASCO). 2015. Understanding Targeted Therapy. Available from: www.cancer.net/navigating-cancer-care/hoecancertreated/personalized-and-targetedtheraphies/understanding-targeted-therapy. (Diakses 30 Desember 2018) American Society of Clinical Oncology (ASCO). 2017. Cancer-Related Fatigue. American Society of Clinical Oncology, p. 1. BC Cancer Agency. 2008. BC Cancer Agency Cancer Drug Manual, Vincristine. BC Cancer Agency, p. 1-4. BC Cancer Agency. 2010. BC Cancer Agency Cancer Drug Manual, Ifosfamide. BC Cancer Agency1, p. 1-5. BC Cancer Agency. 2011. BCCA Protocol Summary for Management of Hypersensitivity Reactions to Chemotherapeutic Agents. BC Cancer Agency, p. 1-2. BC Cancer Agency. 2013. BC Cancer Agency Cancer Drug Manual, Cyclophosphamide. BC Cancer Agency, p. 1-4. BC Cancer Agency. 2015. BC Cancer Agency Cancer Drug Manual, Epirubicin. BC Cancer Agency, p. 1-5.. 86 SKRIPSI. STUDI PENGGUNAAN KEMOTERAPI.... DIRANI.

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 87 BC Cancer Agency. 2017. BC Cancer Agency Cancer Drug Manual, Doxorubicin. BC Cancer Agency1, p. 1-9. BC Cancer Agency. 2017. BC Cancer Agency Cancer Drug Manual, Etoposide. BC Cancer Agency2, p. 1-4. BC Cancer Agency. 2017. BC Cancer Agency Cancer Drug Manual, Methotrexate. BC Cancer Agency3, p. 1-6. BC Cancer Agency. 2017. BC Cancer Agency Protocol Summary for Treatment of Advanced Indolent Lymphoma using Cyclophosphamide, Vincristine, Prednisone and Rituximab. BC Cancer Agency4, p. 2. BC Cancer Agency. 2018. BC Cancer Agency Guidelines for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting in Adults. BC Cancer Agency1, p. 2. BC Cancer Agency. 2018. BC Cancer Agency Protocol Summary for Treatment of Lymphoma with Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (CHOP-R). BC Cancer Agency, p. 2. Boediwarsono. 2000. A Problem of Malignant Lymphoma Management In Indonesia. Folia Medica Indonesiana. Vol. 36, p. 32-37. Castillo, Jorge J., Ghobrial, Irene M., Treon, Steven P. 2015. Biology, Prognosis, and Therapy of Waldenström Macroglobulinemia. Cancer Treatment and Research. Vol. 165, p. 177-196. Cheson, BD., Fisher, RI., Barrington, SF., Cavalli, F., Schwartz, LH., Zucca, E., Lister, TA. 2014. Recommendation for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. Journal of Clinical Oncology. Vol. 32, p. 3059-3067. Chiu, Brian C.-H., Hou, Ningqi. 2015. Epidemiology and Etiology of Non-Hodgkin Lymphoma. Cancer Treatment and Research. Vol. 165, p. 1-26. Dark, Graham G. 2013. Chapter 1 : The Global Burden of Cancer. In: Dark, Graham G. Oncology at a Glance, First Edition. UK : John Wiley & Sons, Ltd, p. 10-11. Dwianingsih, Ery Kus., Indrawati., Hardianti, Mardiah Suci., Malueka, Rusdy Ghazali., Iswar, Riezka Rivani., Sutapa, Stefani APPG.,. SKRIPSI. STUDI PENGGUNAAN KEMOTERAPI.... DIRANI.

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 88 Trianingsih, FX Ediati. 2016. Histopathological Features of Lymphoma in Yogyakarta Indonesia. Asian Pacific Journal of Cancer Prevention. Vol. 12, p. 4213-4216. Eisenhauer, EA., Therasse, P., Bogaerts J., Schwartz, LH., Sargent D., Ford R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., Rubinstein, L., Shankar, L., Dodd, L., Kaplan, R., Lacombe, D., Verweiji, J. 2009. New Response Evaluation Criteria in Solid Tumours: revised RECIST guideline. European Journal of Cancer. Vol. 45, p. 228-247. Fausel, Chris. 2008. Chapter 90 : Malignant Lhymphomas In: ChisholBurns, Marie A., Wells, Barbara G., Schwinghammer, Terry L., Malone, Patrick M., Kolesar, Jill M., Rotschafer, John., Dipiro, J.T. Pharmacotherapy Principle & Practice. United State of America: The McGraw-Hill Education, p. 1371-1384. Globocan-IARC. 2012. Estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer, World Health Organization. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. (Diakses tanggal 28 Oktober 2018). Gordon, Katherine A., Tosti, Antonella. 2011. Alopecia: Evaluation and Treatment. Clinical, Cosmetics and Investigational Dermatology. Vol. 4, p.101-106. Hamidah, Prenggono., Darwin, M., Heriyani, Farida. 2016. Perbedaan Kadar LDH Serum Total Sebelum dan Sesudah Kemoterapi Pada Berbagai Kelompok Stadium Kanker LNH. Berkala Kedokteran. Vol. 12(1), p. 49-60. Hardjono, Suko. 2016. Hubungan Struktur-Aktivitas Obat Antikanker. Kimia Medisinal. Surabaya: Pusat Penerbitan dan Percetakan Unair, p. 163-181. Hecht, Keith A., Liewer, Susanne E. 2016. Chapter 97: Malignant Lymphomas. In: Chisholm-Burns, M., Schwinghammer, T., Wells, B., Malone, P., Kolesar, J.M., Dipiro, J.T. (Eds.). Pharmacotherapy Principles and Practice Fourth Edition. New York : The McGraw-Hill Education, p. 1433-1459. Jaffe, Elaine S., Pittaluga, Stefania., Anastasi John. 2018. Chapter 73: The Pathologic Basis For The Classification of Non-Hodgkin And Hodgkin Lymphomas. In: Hoffman, R., Benz, Edward J.,. SKRIPSI. STUDI PENGGUNAAN KEMOTERAPI.... DIRANI.

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 89 Silberstein, Leslie E., Heslop, Helen., Weitz, J., Anastasi, J. Hematology: Diagnosis and Treatment, p. 1187-1203. Jacobson, Joseph O., Polovich, Martha., Gilmore, Terry R., Schulmeister, Lisa., Esper, Peg., LeFebvre, Kristine B., Neuss, Michael N. 2012. Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards: Expanding the Scope to Include Inpatient Settings. Oncology Nursing Forum. Vol. 39, p. 31-38. Jo, J., Yoon, D.H., Lee, S., Park, C., Huh, J., Lee, K., Kang, E.H., Kim, S., Suh, C. 2012. Efficacy and Safety of ReducedDose Intensity R-CHOP in Elderly Patients with Diffuse Large B Cell Lymphoma. Blood. Vol. 120(21), p. 3674. Kementerian Kesehatan Republik Indonesia. 2015. Data dan Kondisi Penyakit Limfoma di Indonesia. Jakarta: Kementerian Kesehatan Republik Indonesia, p. 1-4. Kementerian Kesehatan Republik Indonesia, 2015. Penatalaksanaan Limfoma Non-Hodgkin. Kementerian Kesehatan Republik Indonesia, p. 1-18.. Panduan Jakarta:. Kubuschok, Boris., Held, Gerhard., Pfreundschuh, Michael. 2015. Management of Diffuse Large B-Cell Lymphoma (DLBCL). Cancer Treatment and Research. Vol. 165, p. 271-282. Lamar, Zanetta S. 2016. The Role of Glucocorticoids in the Treatment of Non Hodgkin Lymphoma. Annals of Hematology & Oncology. Vol. 3, p. 1103. Legant, P. 2012. Oncologist and Medical Malpractice. Journal of Oncology Practice. Vol. 2, No. 4, p. 164-169. Leval, Laurence. 2018. Non-Hodgkin Lymphomas: Pathology and Genetics. Encyclopedia of Cancer, 3rd Edition, p. 4-6. London Cancer North and East. 2015. Guidelines for The Management of non Hodgkin's and Hodgkin's Lymphoma in Adults. London Cancer North and East, p. 36-48. Longo, Dan L. 2015. Chapter 134 : Malignancies of Lhymphoid Cells. In: Kasper, D. L., Hauser, S.L., Jameson, J.L., Fauci, A.S., Longo, D.L., Loscalzo, J. (Eds.). Harrison’s Principles of Internal. SKRIPSI. STUDI PENGGUNAAN KEMOTERAPI.... DIRANI.

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 90 Medicine 19th Edition. New York : The McGraw-Hill Education, p. 695-710. MacNaughton, Wallace. K., Sharkey, Keith A. 2017. Chapter 51. Pharmachotherapy of Inflammatory Bowel Disease. In: Brunton, L., Hilal-Dandan, Randa., Knollmann, Bjoorn C. Goodman & Gilman’s: The Pharmacological Basis of Theurapeutics 13th edition. United State: The McGraw-Hill Companies Inc. Lange, p. 948. Mansi, Janine. 2013. Generic Chemotherapy Protocol Guidelines. NHS South East London Cancer Network, p. 3-5. Markman, Margaret R., Peterson, G., Kulp, B., Markman, M. 2002. Effectiveness of Serotonin-Receptor Antagonist Antiemetic Therapy over Successive Courses of Carboplatin-Based Chemotherapy. Gynecologic Oncology. Vol. 85(3), p. 435-437. Mengko, Steward K., Surarso, Bakti. 2009. Patogenesis Limfoma Non Hodgkin Ekstra Nodal Kepala dan Leher. Jurnal THT-KL. Vol. 2(1), p. 32-47. Morgan, J. G., Mikhail, M. S., Murray, M. 2013. Clinical Anesthesiology 5th Edition. New York: Mcgraw-Hill Companies, p. 283-286. National Cancer Institute. 2017. Estimated New Cancer Cases and Deaths for 2017 All Races, By Sex. SEER Cancer Statistics Review 1975-2014, p. 1. National Cancer Institute. 2017. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. US Departement of Health and Human Services, p. 3-4, 25. National Comprehensive Cancer Network. 2014. Non-Hodgkin's Lymphomas. National Comprehensive Cancer Network, p. 5870. National Comprehensive Cancer Network. 2016. Diffuse Large B-Cell Lymphoma R-CHOP (Cyclophosphamide /Doxorubicin /Vincristine/ Prednisone + Rituximab). National Comprehensive Cancer Network, p. 1. National. SKRIPSI. Comprehensive Cancer Network. 2018. Non-Hodgkin Lymphoma Treatment Regimens: Diffuse Large B-Cell Lymphoma. National Comprehensive Cancer Network, p. 1-3.. STUDI PENGGUNAAN KEMOTERAPI.... DIRANI.

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 91 O'brien, Christopher P. 2009. Management of Stomatitis. Canadian Family Physician. Vol. 55, p. 891-892. Oncology Nursing Society. 2014. Emetogenic Risk of Chemotherapy and Biotherapy Agents. Oncology Nursing Society, p. 1-2. Ondrejka, Sarah L., Hsi, Eric D. 2015. Pathology of B-Cell Lymphomas: Diagnosis and Biomarker Discovery. Cancer Treatment and Research. Vol. 165, p. 1-26. Oun, Rabbab., Moussa, Yvonne E., Wheate, Nial J. 2018. The Side Effect of Platinum-Based Chemotherapy Drugs: a Review for Chemists. The Royal Society of Chemistry. Vol. 47, p. 6645-6653. Paramartha I Kadek Adi., Rena Renny A, 2017. Karakteristik Pasien Limfoma Maligna di RSUP Sanglah Tahun 2015. E-Jurnal Medika. Vol. 6, p.1-9. Patrick, J.M & Chris, F. 2008. Cancer Treatment and Chemotherapy. Dipiro, T.J., Talbert L.R., Yee, Gary. C., Matzke, R.G., Wells, G.B., Posey, M.L., 2008. In:Pharmacotherapy A Pathophysiologic Approach, Ed7th USA: The McGraw-Hill., Co. Inc. p. 2085-2120. Perhompedin. 2010. Panduan Tatalaksana Perhompedin: Penatalaksanaan Limfoma Non Hodgkin. Perhompedin, p. 110. Peri, Yogev., Agmon-Levin, Nancy., Theodor, E., Shoenfeld, Y. 2012. Sjorgen's Syndrome, The Old and The New. Best Practice & Research Clinical Rheumatology. Vol. 26(1), p. 105-117. Perry, M. C., Doll, D. C., Freter, Carl E. 2012. Perry’s The Chemotherapy Source Book 5th Edition. Philadelphia: Lippincott Williams & Wilkins, p. 112-248. Reksodiputro, A. H. 2015. Multicentre Epidemiology and Survival Study of B Cell Non Hodgkin Lymphoma Patients In Indonesia. J Blood Disorder Transfusion. Vol. 6, p. 1-5. Rubenstein, J. L., Gupta, N. K., Mannis, G. N., LaMarre, A. K., Treseler, P. 2013. How I Treat CNS Lymphoma. The American Society of Hematology. Vol. 122(14), p. 3061-3067. Sabath, Daniel E. 2014. Chapter 13 : Disease of White Blood Cells, Lymph Nodes, and Spleen. In : Agrawal, Y P., Aleryani, S L.,. SKRIPSI. STUDI PENGGUNAAN KEMOTERAPI.... DIRANI.

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 92 Alter, D N., Apple, Fred S., Dawlin, S P. Laboratory Medicine: The Diagnosis of Disease in the Clinical Laboratory, Second Edition. New York : The McGraw-Hill Education, p. 588-606. Salma, Rina S., Bintoro, Ugroseno Y., Sedana, Made P. 2018. CHOP and R-CHOP Therapeutic Responses in Non Hodgkin Lymphoma Patients in Dr. Soetomo General Hospital Surabaya. Biomolecular and Health Science Journal. Vol. 2, p. 93-96. Schimmer, Bernasrd P., Funder, John W. 2017. Chapter 46. Adrenocorticotropic Hormonr, Adrenal Steroids , and the Adrenal Cortex. In: Brunton, L., Hilal-Dandan, Randa., Knollmann, Bjoorn C. Goodman & Gilman’s: The Pharmacological Basis of Theurapeutics 13th edition. United State: The McGraw-Hill Companies Inc. Lange, p. 860. Shalini, S., Ravichandran V., Mohanty Bk, Dhanaraj SK., and Saraswathi R. 2010. Drug Utilization Studies – An Overview. International Journal of Pharmaceutical Sciences and Nanotechnology 3. Vol. 1, p. 803-807. Shankland, Kate R., Armitage, James O., Hancock, Barry W. 2012. NonHodgkin lymphoma. The Lancet. Vol. 380, p. 848-857. Siegel, R. L., Miller, K. D., Jemal, A. 2016. Cancer Statitics, 2016. CA: A Cancer Journal for Clinicians. Vol. 66 (1), p. 7-30. Sisay, Eskinder Ayalew., Engidawork, Ephrem., Yesuf, T. A., Ketema, E. B., 2015. Drug Related Problems in Chemotherapy of Cancer Patients. Journal of Cancer Science and Therapy. Vol. 7, p. 055-059. Sukardja, I.D.G. 2010. Onkologi Klinik, Edisi 2, Surabaya: Airlangga University Press, p. 41-44, 54-64, 111-125. Swerdlow, Steven H., Campo, Elias., Pileri, Stefano A., Harris, Nancy Lee., Stein, Harald., Siebert, Reiner., Advani, Ranjana., Ghielmini, Michele., Salles, Gilles A., Zelenetz, Andrew D., Jaffe, Elaine S. 2016. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood Journal. Vol. 127, p. 2375-2390. Sweetman, S. C. 2009. Martindale: The Complete Drug Reference Thirty Sixth Edition. London: Pharmaceutical Press, p. 14951496, 1772-1773.. SKRIPSI. STUDI PENGGUNAAN KEMOTERAPI.... DIRANI.

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 93 Ugroseno., Ali, Muhammad., Boediwarsono. 2009. Lactate Dehydrogenase Level and The Response of Non Hodgkin Lymphoma Patintes to Chemotherapy Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP). Folia Medica Indonesiana. Vol. 44(3), p. 184-187. World Health Organization. 2003. Introduction to Drug Utilization Research. Norway : WHO Library Cataloguing, p. 6-10. Winkfield, Karen M., Tsang, Richard W., Gospodarowicz, Mary K. 2016. Chapter 77 : Non-Hodgkin’s Lymphoma. In : Winkfield, Karen M., Tsang, Richard W., Gospodarowicz, Mary K. Clinical Radiation Oncology, p. 1524-1546. Yaniari, Roethmia. 2016. Hubungan Antara Titer Antibodi Anti Rituximab (R) dengan Respon Terapi Pada Pasien Limfoma Non Hodgkin Yang Mendapatkan R-CHOP. Departemen SMF Ilmu Penyakit Dalam. Fakultas Kedokteran. Universitas Airlangga Surabaya, p. 50-61.. SKRIPSI. STUDI PENGGUNAAN KEMOTERAPI.... DIRANI.